After prolonged treatment, a biopsy of the same site revealed SCLC based on the exon 19 mutation of the epidermal growth factor receptor (EGFR), which was consistent with primary NSCLC [13]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.